Hovione increases production capacity
‘One Site Shop’ expands to respond to growing demands
Oops! Your browser version is not supported by our website.
Please use these following browsers to view this page:
‘One Site Shop’ expands to respond to growing demands
Pharmaceutical Technology, 2 Junho 2021
Its lead single-use nasal dry powder device now available for commercial partnerships
Hovione announced today that it held on June 8th the official groundbreaking for the expansion of its New Jersey facility in East Windsor, USA
High Performance, High-Dose Capsule DPI.
Hovione today announced that it plans to host and operate a commercial-scale continuous manufacturing facility as part of an agreement with Vertex Pharmaceuticals
Manufacturing Chemist, 3 May 2023
Commitment to partnership and joint innovation for cell and gene therapies
Hovione´s pragmatic approach to bridging science with manufacturing is now being leveraged for continuous tableting and it is the key to ultimately providing high quality medicines and the success of your drug product.